Faster Approval of New Medical Products Heightens Uncertainty Over Risks

As new drugs and medical devices make their way through the FDA’s approval process at an accelerated rate, research on their safety and efficacy is not always as rigorous as it should be, experts cautioned at a AAAS event.

Read the article: